Article
Chiral separations in polar organic solvent chromatography: updating a screening strategy with new chlorine-containing polysaccharide-based selectors.
Department of Analytical Chemistry and Pharmaceutical Technology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
Journal of Chromatography B (impact factor:
2.89).
09/2008;
875(1):57-64.
DOI:10.1016/j.jchromb.2008.07.038
pp.57-64
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Enantioselective synthesis and antioxidant activity of 3-(3,4-dihydroxyphenyl)-glyceric acid--basic monomeric moiety of a biologically active polyether from Symphytum asperum and S. caucasicum.
[show abstract] [hide abstract]
ABSTRACT: The racemic and enantioselective synthesis of a novel glyceric acid derivative, namely, 2,3-dihydroxy-3-(3,4-dihydroxyphenyl)-propionic acid as well as the antioxidant activities is described. The virtually pure enantiomers, (+)-(2R,3S)-2,3-dihydroxy-3-(3,4-dihydroxyphenyl)-propionic acid and (-)-(2S,3R)-2,3-dihydroxy-3-(3,4-dihydroxyphenyl)-propionic acid were synthesized for the first time via Sharpless asymmetric dihydroxylation of trans-caffeic acid derivatives using the enantiocomplementary catalysts, (DHQD)(2)-PHAL and (DHQ)(2)-PHAL. The determination of enantiomeric purity of the novel chiral glyceric acid derivatives was performed by high-performance liquid chromatographic techniques on the stage of their alkylated precursors. The novel glyceric acid derivatives show strong antioxidant activity against hypochlorite and N,N-diphenyl-N-picryl-hydrazyl free radical. Their antioxidant activity is about 40-fold higher than that of the corresponding natural polyether and three-fold higher of trans-caffeic acid itself.Chirality 02/2010; 22(8):717-25. · 2.35 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
added value
chiral drug substances
Chiralpak AS-RH
chlorine-containing chiral stationary phases
complementarity reasons
different compounds
existing column
four phases
higher success rate
improved success rates
joint results
mobile phase selection strategy
new chlorine-containing polysaccharide-based stationary phases
new phases
non-chlorine-containing ones
polar organic solvent liquid chromatography
screening process
six phases
two mobile phases
two new phases